Hermetica Superfood Encyclopedia
The Short Answer
Solanum nodiflorum belongs to the Solanum genus, which characteristically contains steroidal alkaloids and saponins that modulate apoptotic pathways and inflammatory mediators, though these compounds have not yet been quantified or confirmed specifically in this species. No clinical trials exist for S. nodiflorum itself, and available evidence is confined to genus-level preclinical data from closely related species such as S. nigrum, limiting any conclusions about efficacy or safety.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary Keywordwhite nightshade Solanum nodiflorum
White Nightshade — botanical close-up
Health Benefits
**Potential Antitumor Activity**
Related Solanum species exhibit apoptosis induction via caspase-3 activation and Bcl-2 downregulation; these mechanisms are plausible but entirely unconfirmed in S. nodiflorum.
**Putative Anti-inflammatory Effects**
Steroidal alkaloids and saponins found in genus members reduce nitric oxide production and superoxide generation in vitro (IC50 as low as 2.87 µM for saponins in S. nigrum), though equivalent data for S. nodiflorum are absent.
**Antioxidant Properties**
Phenolic compounds and flavonoids common across Solanum spp. scavenge free radicals and reduce oxidative stress in hepatotoxicity models; whether S. nodiflorum accumulates comparable phenolic concentrations is uncharacterized.
**Traditional Hepatoprotective Use**
Fruits of closely related black nightshade have demonstrated protection against oxidative hepatotoxicity in animal models; S. nodiflorum is used in analogous traditional contexts in parts of Africa, but mechanistic or clinical validation is lacking.
**Possible Antihyperglycemic Potential**: Campesterol isolated from S
nigrum leaves showed anti-hyperglycemic activity in alloxan-induced diabetic rats; this phytosterol may occur in S. nodiflorum given genus biosynthetic pathways, but this remains speculative without dedicated phytochemical screening.
**Antimicrobial Properties**
Crude extracts of multiple Solanum species demonstrate activity against bacterial and fungal pathogens in disk diffusion assays; S. nodiflorum ethnobotanical reports mention wound and skin infection applications consistent with this genus-level activity.
Origin & History
Natural habitat
Solanum nodiflorum is a pantropical weed native to sub-Saharan Africa, now naturalized across tropical and subtropical regions including Asia, Australia, and the Americas. It thrives in disturbed soils, roadsides, agricultural margins, and open waste ground at low to mid elevations, tolerating a wide range of soil types. The plant is not formally cultivated but is harvested opportunistically in traditional contexts alongside other edible and medicinal nightshade species.
“Solanum nodiflorum has been documented as a common weedy plant in traditional African agricultural landscapes, where several nightshade species are gathered both as leafy vegetables and as informal remedies for inflammatory and hepatic complaints. Its close relatives, particularly S. nigrum and S. americanum, have a multi-millennium history of medicinal use in Ayurvedic, Traditional Chinese Medicine, and indigenous African systems, primarily for liver protection, wound healing, and fever management. Traditional healers in parts of East and Southern Africa have applied nightshade species topically for skin infections and internally as decoctions for gastrointestinal and urinary complaints, and S. nodiflorum may have been used interchangeably with morphologically similar congeners under shared vernacular names. The species' exact historical medicinal identity is complicated by widespread taxonomic confusion among small-fruited white-flowered Solanum weeds, meaning recorded traditional uses may conflate S. nodiflorum with S. nigrum, S. americanum, or S. photeinocarpum.”Traditional Medicine
Scientific Research
No peer-reviewed pharmacological or clinical studies have been published specifically on Solanum nodiflorum as of the available literature, representing a substantive research gap for this species. Evidence for the genus is dominated by S. nigrum, for which over 188 isolated compounds have been characterized across in vitro cytotoxicity assays, enzyme inhibition models, and limited rodent studies, but no controlled human trials with reported sample sizes or effect sizes have been identified. Cytotoxicity data for S. nigrum fractions show LC50 values of 10.54–27.59 µg/mL, and an antidepressant-like compound tovanal A was effective at 10–30 mg/kg in rodent models, providing mechanistic leads but not clinical guidance applicable to S. nodiflorum. The overall evidence base is preclinical, taxonomically indirect, and insufficient to support any therapeutic claim for white nightshade.
Preparation & Dosage
Traditional preparation
**Traditional Whole-Plant Decoction**
Leaves and stems boiled in water in analogous African nightshade preparations; no validated dose established for S. nodiflorum specifically.
**Crude Aqueous or Ethanolic Extract**
Used in laboratory settings for related species; no standardized concentration or dosage range confirmed for S. nodiflorum.
**Fruit Preparation (Genus Reference)**
Ripe or cooked fruits of related nightshades consumed as food or tonic in traditional African cuisine; raw consumption of unripe fruits poses glycoalkaloid toxicity risk across the genus.
**Rodent Study Reference Dose (S. nigrum Compounds)**
10–30 mg/kg in animal antidepressant models; not translatable to human dosing for S
Tovanal A administered at . nodiflorum without dedicated studies.
**Standardization**
No commercial standardization exists for S. nodiflorum extracts; any future formulation would require quantification of alkaloid and saponin content to define safe concentration ranges.
**Timing**
No data available; genus-level pharmacokinetics suggest oral administration with food may modify absorption of phenolic and alkaloid fractions.
Nutritional Profile
Detailed macronutrient and micronutrient analyses specific to Solanum nodiflorum have not been published. By analogy with edible African nightshades (S. scabrum, S. nigrum), leaves are expected to be rich in water (80–90% fresh weight), with moderate protein content (approximately 3–5% dry weight), low fat, and dietary fiber. Genus members accumulate iron, calcium, and beta-carotene at nutritionally relevant concentrations in leaves, and phenolic compounds including rutin, chlorogenic acid, and caffeic acid contribute antioxidant capacity. Steroidal glycoalkaloids—including solanine-type compounds—are present across the genus and represent a dual nutritional and toxicological consideration; concentrations increase in unripe fruits and stressed plant tissue, and bioavailability of both nutrients and alkaloids is modified by cooking and food matrix interactions.
How It Works
Mechanism of Action
In well-studied congeners such as S. nigrum, steroidal saponins trigger intrinsic apoptosis by upregulating pro-apoptotic proteins Bax and Bid, activating executioner caspase-3, cleaving PARP, and downregulating the survival protein Bcl-2 in tumor cell lines. Steroidal alkaloids including solasonine and solamargine intercalate into lipid bilayers and disrupt membrane integrity, while lignanamides suppress inducible nitric oxide synthase activity with IC50 values ranging from 5.1 to 58.5 µM, attenuating inflammatory signaling. Phenolic constituents inhibit digestive enzymes α-glucosidase, α-amylase, and lipase, an effect potentiated after simulated gastrointestinal digestion due to liberation of condensed tannins from the food matrix. Because no phytochemical or pharmacological studies have been conducted on S. nodiflorum specifically, extrapolation of these mechanisms from related species must be treated as hypothetical pending direct investigation.
Clinical Evidence
No clinical trials—randomized, observational, or otherwise—have been conducted using Solanum nodiflorum as an intervention in human subjects. The closest proxy evidence derives from preclinical studies on S. nigrum, including one rat model demonstrating anti-hyperglycemic activity attributed to campesterol, but quantitative metrics such as effect sizes, confidence intervals, or standardized dose–response relationships were not reported in accessible literature. Without human pharmacokinetic data, dose-ranging studies, or safety monitoring data for S. nodiflorum, no clinical conclusions can be drawn, and its therapeutic profile remains entirely inferential. Confidence in any purported health benefit is therefore very low, and the ingredient should not be recommended for therapeutic use outside of formally supervised research contexts.
Safety & Interactions
Solanum nodiflorum contains glycoalkaloids characteristic of the genus, including solanine-type and solasodine-type compounds that inhibit acetylcholinesterase and disrupt cell membranes; acute poisoning risk is highest with unripe fruit consumption, consistent with toxicity reports for related nightshades. Cytotoxicity assays on S. nigrum fractions yielded LC50 values of 10.54–27.59 µg/mL, indicating meaningful cellular toxicity at relatively low concentrations and warranting caution with concentrated extracts. No formal drug interaction studies exist for S. nodiflorum, but genus-level data suggest potential interactions with anticholinesterase medications, immunosuppressants, and cytochrome P450-metabolized drugs due to alkaloid and flavonoid content. Pregnant and lactating individuals should avoid therapeutic use given the absence of safety data and known teratogenic and abortifacient potential of high-dose Solanum alkaloids in animal models; no maximum safe dose has been established.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Solanum nodiflorumSolanum nodiflorum Jacq.glossy nightshadesmall-fruited black nightshadewhite-berried nightshade
Frequently Asked Questions
Is white nightshade (Solanum nodiflorum) safe to eat or use medicinally?
Solanum nodiflorum has not been evaluated in human safety studies, and its glycoalkaloid content—characteristic of all Solanum species—poses a risk of toxicity, particularly from unripe fruits or concentrated extracts. Related species such as S. nigrum show cytotoxicity at LC50 values of 10–27 µg/mL in cell-based assays, suggesting caution is warranted. Until dedicated toxicological and clinical studies are completed, therapeutic use of S. nodiflorum cannot be considered safe or evidence-based.
What are the active compounds in white nightshade?
No phytochemical studies have specifically characterized the bioactive compounds of Solanum nodiflorum. Based on genus-level chemistry, it likely contains steroidal alkaloids (such as solanine-type glycoalkaloids), steroidal saponins, phenolic acids, flavonoids, and phytosterols such as campesterol, mirroring the approximately 188 compounds catalogued in S. nigrum. Quantitative data on concentrations of any compound in S. nodiflorum are not available in the published literature.
How is white nightshade used in traditional African medicine?
Solanum nodiflorum is recognized as a common weed in sub-Saharan Africa and is associated with the broader group of edible and medicinal nightshades used traditionally for liver complaints, inflammation, fever, and skin infections. However, its specific documented traditional uses are poorly separated from those of morphologically similar species such as S. nigrum and S. americanum, with which it shares common vernacular names in many regions. Preparations typically involve leaf decoctions or topical poultices, consistent with traditional nightshade practices across the continent.
How does Solanum nodiflorum differ from black nightshade (Solanum nigrum)?
Solanum nodiflorum and S. nigrum are closely related small-flowered weedy nightshades that are frequently confused in both botanical literature and ethnobotanical records; both bear small white flowers and dark to pale berries. S. nigrum has been the subject of extensive phytochemical and pharmacological research, with over 188 compounds isolated, while S. nodiflorum remains essentially unstudied scientifically. Morphologically, S. nodiflorum tends to produce slightly smaller, more nodding flower clusters and is more commonly found in warmer lowland tropical habitats, but reliable identification requires herbarium-level botanical assessment.
Are there any clinical trials on white nightshade?
No clinical trials—randomized controlled or otherwise—have been registered or published for Solanum nodiflorum in human subjects as of current available evidence. The closest related human-relevant data come from preclinical rodent studies on S. nigrum, which demonstrated anti-hyperglycemic effects in alloxan-induced diabetic rat models and antidepressant-like activity for isolated compound tovanal A at 10–30 mg/kg, but these findings cannot be directly applied to S. nodiflorum. Dedicated phase I safety trials and phytochemical characterization studies would be necessary prerequisites before any clinical application.
What forms of white nightshade are available, and does the form affect its bioavailability?
White nightshade is traditionally prepared as a whole-plant decoction or infusion, and in some supplement contexts as dried powder or extract preparations. The steroidal alkaloids and saponins responsible for purported anti-inflammatory effects are water-soluble, making decoctions and aqueous extracts the most historically supported preparation methods. However, no comparative bioavailability studies exist to confirm whether extracts, powders, or whole-plant preparations deliver superior absorption or efficacy in humans.
What does the current research evidence say about white nightshade's anti-inflammatory and antitumor claims?
In vitro studies on related Solanum species demonstrate anti-inflammatory activity through reduced nitric oxide and superoxide production at low concentrations (IC50 values as low as 2.87 µM), and some Solanum relatives show apoptosis induction via caspase-3 activation. However, these mechanisms remain entirely unconfirmed in white nightshade (Solanum nodiflorum) specifically, and no human clinical trials have evaluated anti-inflammatory or antitumor efficacy. Current evidence is preliminary laboratory-based research that cannot yet support therapeutic claims for humans.
Who should avoid white nightshade, and are there populations at particular risk?
Pregnant and nursing women should avoid white nightshade due to the presence of steroidal alkaloids, which have teratogenic and reproductive toxicity potential in other nightshade species. Children and individuals with liver or kidney impairment are also at higher risk for alkaloid accumulation and toxicity. People with a history of solanine sensitivity or other nightshade family reactions should exercise caution, as cross-reactivity is possible.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w white-nightshade-solanum-nodiflorum curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
